{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:07:17Z","timestamp":1788516437760,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taiwan Centers for Disease Control","award":["DOH99-DC-2038"],"award-info":[{"award-number":["DOH99-DC-2038"]}]},{"DOI":"10.13039\/100009210","name":"Taiwan Food and Drug Administration","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.01.013","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T05:54:41Z","timestamp":1326866081000},"page":"2168-2172","source":"Crossref","is-referenced-by-count":32,"title":["The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture\u2013recapture analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Wan-Ting","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-I","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.01.013_bib0005","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1016\/j.vaccine.2010.08.069","article-title":"Design of a robust infrastructure to monitor the safety of the pandemic A (H1N1) 2009 vaccination program in Taiwan","volume":"28","author":"Huang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0015","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/154.11.1006","article-title":"Enhancing vaccine safety surveillance: a capture\u2013recapture analysis of intussusception after rotavirus vaccination","volume":"154","author":"Verstraeten","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.vaccine.2010.10.067","article-title":"Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting","volume":"29","author":"Carvajal","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0030","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1542\/peds.2007-3793","article-title":"Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006 to September 25, 2007","volume":"121","author":"Haber","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/oxfordjournals.epirev.a036192","article-title":"Capture\u2013recapture methods in epidemiology: methods and limitations","volume":"17","author":"Hook","year":"1995","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0040","first-page":"1047","article-title":"Capture\u2013recapture and multiple-record systems estimation I: history and theoretical development","volume":"142","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/oxfordjournals.aje.a117559","article-title":"Capture\u2013recapture and multiple-record systems estimation II: applications in human diseases","volume":"142","author":"International Working Group for Disease Monitoring and Forecasting","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0050","unstructured":"Department of Health, Executive Yuan Pharmacovigilance in Taiwan. Available at http:\/\/adr.doh.gov.tw\/ADR-eng\/index.htm [accessed August 31, 2011]."},{"key":"10.1016\/j.vaccine.2012.01.013_bib0055","unstructured":"European Medicines Agency CHMP recommendations for the pharmacovigilance plan as part of the risk management plan to be submitted with the marketing authorization application for a pandemic influenza vaccine. Available at http:\/\/www.emea.eu\/docs\/en_GB\/document_library\/Report\/2010\/01\/WC500051739.pdf [accessed August 31, 2011]."},{"key":"10.1016\/j.vaccine.2012.01.013_bib0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0065","unstructured":"Department of Health, Executive Yuan National Death Certification System [Chinese]. Available at http:\/\/das.doh.gov.tw\/DAS\/ [accessed August 31, 2011]."},{"key":"10.1016\/j.vaccine.2012.01.013_bib0070","unstructured":"Bureau of National Health Insurance. National Health Insurance in Taiwan; 2010. Available at http:\/\/www.nhi.gov.tw\/webdata\/AttachFiles\/Attach_13767_1_National%20Health%20Insurance%20in%20Taiwan%202010.pdf [accessed August 31, 2011]."},{"key":"10.1016\/j.vaccine.2012.01.013_bib0075","series-title":"Some properties of the hypergeometric distribution with applications to zoological sample censuses","author":"Chapman","year":"1951"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2307\/2529040","article-title":"The effect of trap response on tag recapture estimates","volume":"26","author":"Seber","year":"1970","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0085","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)60515-6","article-title":"Monitoring the safety of pandemic H1N1 vaccine","volume":"375","author":"Huang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0090","doi-asserted-by":"crossref","unstructured":"Office of Statistics Department of Health. Mortality Statistics; 2010 [Chinese]. Available at http:\/\/www.doh.gov.tw\/CHT2006\/DM\/DM2_2.aspx?now_fod_list_no=11962&class_no=440&level_no=4 [accessed October 10, 2011].","DOI":"10.1016\/S0262-1762(11)70310-8"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0095","first-page":"1","article-title":"Epidemiology of adverse reactions to non-steroidal anti-inflammatory drugs","volume":"6","author":"Weber","year":"1984","journal-title":"Adv Inflamm Res"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0100","series-title":"H1N1 vaccine safety monitoring: global lessons for a global pandemic; 27th international conference on pharmacoepidemiology & therapeutic risk management","article-title":"The Taiwan experience with pandemic (H1N1) 2009 vaccine safety monitoring","author":"Huang","year":"2011"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0110","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain\u2013Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0115","first-page":"657","article-title":"Preliminary results: surveillance for Guillain\u2013Barr\u00e9 syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine \u2014 United States, 2009\u20132010","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0120","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","article-title":"Guillain\u2013Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case\u2013control study in Europe","volume":"343","author":"Dieleman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/aje\/kwr072","article-title":"Guillain\u2013Barr\u00e9 syndrome, influenza-like illness, and influenza vaccination during seasons with and without circulating A\/H1N1 viruses","volume":"174","author":"Grimaldi-Bensouda","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0175","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1016\/j.vaccine.2011.08.069","article-title":"Guillain\u2013Barr\u00e9 syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series","volume":"29","author":"Andrews","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.013_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink project","volume":"41","author":"Lee","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pds.619","article-title":"The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990\u20131997","volume":"10","author":"Silvers","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/oxfordjournals.aje.a116479","article-title":"Confounding in studies of adverse reactions to vaccines","volume":"136","author":"Fine","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0150","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/aje\/kwp173","article-title":"Influenza vaccination and mortality: differentiating vaccine effects from bias","volume":"170","author":"Fireman","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0155","first-page":"917","article-title":"Recommendations for presentation and evaluation of capture\u2013recapture estimates in epidemiology","volume":"52","author":"Hook","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) \u2014 United States, 1991\u20132001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2012.01.013_bib0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.01.013_bib0170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/hv.2790","article-title":"Bell's palsy and parenteral inactivated influenza vaccine","volume":"2","author":"Stowe","year":"2006","journal-title":"Hum Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T01:51:31Z","timestamp":1588816291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1200028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X1200028X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}